IPOs, Initial Public Offerings: pre & post IPO

6 IPOs Scheduled For The Week Of August 6

Print this entry

Six IPOs are scheduled for the week of July 30.

Bloomin Brands (BLMN)
Based in Tampa, FL, Bloomin Brands (BLMN) scheduled a $300 million IPO with a market capitalization of $1.65 billion at a price range mid-point of $14, for Wednesday, August 8, 2012.

BLMN is one of the largest casual dining restaurant companies in the world with a portfolio of leading, differentiated restaurant concepts.

March 2012 quarter earnings were down 10% from the year earlier period, June quarter earnings are up 17% (at the estimated mid-point) compared to the June 2011 quarter.

CKE (CK)
Based in Carpinteria, CA, CKE scheduled a $200 million IPO with a market capitalization of $840 million at a price range mid-point of $15, for Friday, August 10, 2012.

CK is the fifth largest hamburger Quick Serve Restaurant operator globally. Since Apollo Global Management (APO) took over two years ago, interest payments have exceeded or equaled operating earnings.

Manchester United Ltd. (MANU)
Based in Manchester, UK, Manchester United Ltd. (MANU) scheduled a $301 million IPO with a market capitalization of $3 billion at a price range mid-point of $18, for Friday, August 10, 2012.

MANU is one of the most popular and successful sports teams in the world, playing one of the most popular spectator sports on Earth, soccer.

However, operating profits as a percent of revenue have declined steadily for the past three years.

Performant Financial (PFMT)
Based in Livermore, CA, Performant Financial (PFMT) scheduled a $150 million IPO with a market capitalization of $586 million at a price range mid-point of $13, for August 10, 2012.

PFMT is a debt collector with two main business segments: student loans and healthcare payments.

PFMT is heavily dependent on the federal government.

Peregrine Semiconductor (PSMI)
Based in San Diego, CA, Peregrine Semiconductor (PSMI) scheduled an $83 million IPO with a market capitalization of $495 million at a price range mid-point of $15, for Wednesday, August 8, 2012.

PMSI is a fabless provider of high performance RFICs. PMSI solutions leverage a proprietary UltraCMOS technology, which enables the design, manufacture, and integration of multiple RF, mixed signal, and digital functions on a single chip.

As of June 30, 2012, PMSI had an accumulated deficit of $231.3 million.

Stemline Therapeutics (STML)
Based in New York, NY, Stemline Therapeutics scheduled a $42 million IPO with a market capitalization of $128 million at a price range mid-point of $12 for Tuesday, August 7, 2012.

STML is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing proprietary therapeutics that target both cancer stem cells, or CSCs, and tumor bulk.

STML is a holdover from last week.

Post a Comment

 

Login

Lost your password?